Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine in DFU
NCT07768228Phase 2Recruiting
- Sponsor
- Ain Shams University
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of levocarnitine in diabetic foot ulcer (DFU) (2 arms), sponsored by Ain Shams University. Primary endpoints: Change in Diabetic Foot Ulcer area at 12 weeks and Change in Diabetic Foot Ulcer depth at 12 weeks. Started Sep 2026; status: recruiting.
02
Drugs
levocarnitine
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07768228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07768228.